JPMorgan Cautious on Hims & Hers Amid GLP-1 Shift
Yahoo Finance ·
JPMorgan initiated coverage of Hims & Hers Health with a Neutral rating on Friday, establishing a December 2027 price target of $32. The financial institution balanced the direct-to-consumer health platform's rapid expansion against operational uncertainties tied to its transition toward branded weight-loss treatments. Backed by an alliance with Novo Nordisk, Hims reportedly delivered over 125,000 Wegovy shipments during the initial six weeks following its launch. JPMorgan projects that 2026 GLP-1 revenue will climb 46 percent to $1.1 billion, driven by surging branded volumes that offset decreasing compounded sales. Nevertheless, the analyst emphasized the necessity of monitoring execution in the branded GLP-1 shift, sustained momentum in emerging medical specialties, and overall margin improvement before turning more bullish.
AI 시장 분석
JP Morgan initiated coverage on Hims & Hers Health with a Neutral rating and a December 2027 price target of $32. While Wegovy deliveries through the partnership with Novo Nordisk exceeded 125,000 in just six weeks, execution risks remain regarding the transition to branded obesity treatments. Investors should closely monitor 2026 GLP-1 revenue projections and margin trends during the brand transition process.
상승 영향
- Biotech — The surge in Wegovy deliveries through the partnership with Novo Nordisk and expectations for a massive expansion of US GLP-1 users by 2030 are positive factors.
하락 영향
- Biotech — Execution risks and margin uncertainty exist due to the decline in legacy compounded GLP-1 revenue and the ongoing transition to branded obesity treatments.
AI가 생성한 분석으로 투자 자문이 아닙니다.
DYAX Investor Sentiment
Bullish (Long) 46% · Bearish (Short) 54%
269 participants
Related News
- Tech stocks rally as oil prices fall, inflation remains sticky: AlphaCheck
- Fox's Gasparino says "Paramount’s (PSKY) CEO has "tricks up his sleeve" to get his Warner (WBD) acquisition cleared in California"
- If I Could Only Buy 1 Quantum Computing Stock, This Would Be It
- Stock Market Today: Dow Rallies On Surprise Inflation Data; Nvidia Rebounds, Oracle Jumps (Live Coverage)
- How Far Could Intel Stock Fall After More Than Quadrupling In A Year?
- Nvidia CEO Jensen Huang Dismisses AI Cybersecurity Panic as Marketing Tactic
